CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel
The efficacy and safety of LY2963016 among patients with Type 1 and Type 2 diabetes previously treated with insulin glargine
DOI 10.1055/s-0035-1549538
Bibliografische Angaben
Nachweis in CareLit
Autor:innenD Dahl, LB Lacaya, RK Pollom, LL Ilag, JS Zielonka
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: We evaluated the treatment effect of LY2963016 insulin glargine (LY IGlar) as compared to insulin glargine (Sanofi-Aventis; IGlar) in a subgroup of patients who reported prestudy treatment with IGlar (prior IGlar) for Type 1 diabetes and Type 2 diabetes in 52-week open-label (ELEMENT-1) and 24-week double-blind (ELEMENT-2) randomised studies. Methods: Both studies used unit-to-unit dose conversions fro…
Zitieren
Zitierempfehlung
D Dahl, LB Lacaya, RK Pollom, LL Ilag, JS Zielonka (2015) The efficacy and safety of LY2963016 among patients with Type 1 and Type 2 diabetes previously treated with insulin glargine. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0035-1549538
Mit CareLit weiterarbeiten